ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health behaviors"

  • Abstract Number: 1073 • ACR Convergence 2025

    Development of a Culturally-Tailored Storytelling Intervention to Improve COVID-19 Vaccine Uptake in Black and Latinx Patients with Autoimmune and Inflammatory Rheumatic Diseases

    Maria I. ("Maio") Danila1, Lesley Jackson2, Stephanie Ford3, Mary Wilkenson3, Tiffany Alexander4, Jeroan Allison5, Candace Feldman6, Fred Jenoure7, Jonathan Kay5, Stephenie Lemon8, Kenneth Saag9, Karen Salomon10 and Shilpa Venkatachalam11, 1University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3UAB Division of Clinical Immunology and Rheumatology, Birmingham, AL, 4Community Investigator- AL, Birmingham, AL, 5UMass Chan Medical School, Worcester, MA, 6Brigham and Women's Hospital, Boston, MA, 7Community Investigator- MA, Worcester, MA, 83. Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, Worcester, MA, 9The University of Alabama at Birmingham, Birmingham, AL, 10University of Massachusetts Medical School, Shrewsbury, MA, 11Global Healthy Living Foundation, New York, NY

    Background/Purpose: Black and Latinx individuals with autoimmune and inflammatory rheumatic diseases (AIRD) face disproportionately higher risks of severe COVID-19 outcomes. Despite this elevated risk, vaccine…
  • Abstract Number: 1051 • ACR Convergence 2025

    Mitigating Hydroxychloroquine (HCQ) Nonadherence by Clarifying Misbeliefs Using a Shared Decision-Making Tool (HCQ-SAFE©) Across Two Different Rheumatology Centers

    Isabella Hartel1, David Gazeley2, Jay Patel1, Betty Chewning3, Shelby Gomez4, Jessica Michaud5, Laura Dickmann6, Jon keevil7, Patricia Tellez-giron1, Christie Bartels8 and Shivani Garg9, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3University of Wisconsin, School of Pharmacy, Madison, 4University of Wisconsin, School of Pharmacy, Madison, WI, 5Medical College of Wisconsin, Milwaukee, Madison, WI, 6Medical College of Wisconsin, Milwaukee, Milwaukee, 7N/A, Madison, 8University of Wisconsin School of Medicine and Public Health, Madison, WI, 9University of Madison, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hydroxychloroquine (HCQ) prolongs disease-free and damage-free survival in lupus (SLE). Yet, ~80% of patients stop taking HCQ resulting in poor outcomes including early mortality.…
  • Abstract Number: 1049 • ACR Convergence 2025

    Provider Characteristics and Beliefs and Patient Factors Associated with Long-term Glucocorticoid Use in Patients with Rheumatoid Arthritis

    Michael George1, George Reed2, Kevin Kane3, Dimitrios Pappas4 and Joel Kremer5, 1University of Pennsylvania, Philadelphia, PA, 2University of Massachusetts Chan Medical School, Worcester, MA, 3University of Massachusetts Lowell, Lowell, MA, 4CorEvitas, New York, NY, 5The Corrona Research Foundation, Delray Beach, FL

    Background/Purpose: Guidelines recommend limiting glucocorticoid (GC) use in RA, but 30% of patients continue long-term GCs. Little is known about the influence of provider attitudes…
  • Abstract Number: 2603 • ACR Convergence 2025

    Evaluating the Feasibility, Acceptability, and Behavioral Impact of Brief Action Planning (BAP) Coaching for Physical Activity in Adults with Chronic Knee Symptoms: A Qualitative Study

    Moath Alshahrani1, Kristin Haglund2, Miranda McIlheran2, Rowland Chang3, Pamela Semanik4, Sheikh Iqbal Ahamed2 and Daniel Pinto5, 1Marquette University/ King Khalid University, Milwaukee, WI, 2Marquette University, Milwaukee, WI, 3Northwestern University Feinberg School of Medicine, Chicago, IL, 4Rush uUniversity, Chicago, IL, 5Marquette University, Wauwatosa, WI

    Background/Purpose: Physical activity (PA) improves chronic knee symptoms (CKS) by decreasing pain and improving function, yet many interventions to increase PA are resource-intensive or poorly…
  • Abstract Number: 0793 • ACR Convergence 2025

    The weight of the past: how trauma and resilience shape medication adherence in SLE

    Kai Sun1, Sofia Pozsonyiova1, Amanda Eudy2, Megan Clowse3, Rebecca Sadun1, Mithu Maheswaranathan4, Jayanth Doss5, Nathaniel Harris6, Lisa Criscione-Schreiber4, Connor Drake4, Tamara Somers7, Ralph Snyderman8 and Jennifer Rogers4, 1Duke University, Durham, NC, 2Duke University, Raleigh, NC, 3Duke University, Chapel Hill, NC, 4Duke University School of Medicine, Durham, 5Division of Rheumatology and Immunology, Duke University Department of Medicine, Durham, NC, 6Duke University Medical Center, Durham, NC, 7Duke University School of Medicine, Durham, NC, 8Duke Center for Personalized Health Care, Durham, NC

    Background/Purpose: Medication adherence in SLE is suboptimal and contributes to increased disease activity, organ damage, and mortality. Trauma exposure is common among those with SLE…
  • Abstract Number: 2560 • ACR Convergence 2025

    Quality and Accuracy of TikTok Videos on Axial Spondyloarthritis: A Modified DISCERN Analysis

    Mahiar Rabie and Susan Harwell, University of Tennessee- Nashville, Nashville, TN

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease of the axial skeleton that can cause significant pain and disability. Its variable and often non-specific…
  • Abstract Number: 0382 • ACR Convergence 2025

    Preventative Health Screening Practices Among 666 Women with Systemic Rheumatic Diseases from the Hospital for Special Surgery Rheumatology Women’s Reproductive Health and Wellness Cohort: A Cross-Sectional Analysis

    Sandhya shri Kannayiram1, Amaya Smole2, Lucy Masto3, Yongjay Kim4, Neha Nagpal1, Naiva Manuela Piatchou Donfack1, Deanna Jannat-Khah1, Lisa Mandl1, Sarah Lieber1, Caroline Siegel1, Michael Lockshin5, Lisa Sammaritano1 and Medha Barbhaiya1, 1HOSPITAL FOR SPECIAL SURGERY, New york, NY, 2Hospital for Special Surgery, Brooklyn, NY, 3Hospital for Special Surgery, San Francisco, CA, 4Hospital for Special Surgery, Englewood Cliffs, NJ, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Timely preventative health screenings in women with systemic rheumatic diseases (SRDs), especially those with other chronic conditions or who are on immunosuppressive therapy, may…
  • Abstract Number: 1239 • ACR Convergence 2024

    Innovative Patient Empowerment: Evaluating the Effect of a Physician-created Educational Video and To-do Lists on Promoting Preventive Health Measures in Rheumatic Disease Patients

    Vanessa Bartsch1, Basel Habboub2, Kathrin Standfest1, Johannes Knitza3, Georg Schett4 and Axel Hueber2, 1Division Rheumatology, Klinikum Nuernberg, Nuernberg, Germany, 2Klinikum Nuernberg, Nuernberg, Germany, 3Institute for Digital Medicine, Philipps-University Marburg and University Hospital of Giessen and Marburg, Marburg, Germany, 4Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    Background/Purpose: Patients with inflammatory rheumatic diseases (IRDs) are at higher risk for malignancies and infections. Effective management strategies for these comorbidities are urgently needed. We…
  • Abstract Number: 1256 • ACR Convergence 2024

    Higher Disease Activity in Pediatric Systemic Lupus Erythematosus Is Associated with a Greater Desire for Social Health Education: An Unmet Need in Pediatric Rheumatology

    Kaitlin Kirkpatrick, Melodee Liegl, Ke Yan and Sara Sabbagh, Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: There is limited evidence on the educational needs and preferences of caregivers and adolescents and young adults (AYA) with rheumatic disease (RD) regarding the…
  • Abstract Number: 1323 • ACR Convergence 2024

    Drug Abuse Screening in Patients Who Fulfill the 2016 Fibromyalgia Criteria

    Laura Aline Martinez-Martinez1, Angelica Beltran-Barajas2, Mayra Nadia Quintanar-Cuevas3, David Vera Bustamante4, Itzel Palafox Sosa5, Karyme Zazil Velazquez-Zarza6, Salvador Zuñiga-Roman6 and Luz Angelica Viruel-Mejia7, 1Rheumatology Department - National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 2Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, Mexico City, 3Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, México, Mexico, 4Benemerita Universidad Autonoma de Puebla, Heroica Puebla de Zaragoza, Puebla, Mexico, 5Escuela Superior de Medicina-Instituto Politecnico Nacional, Ciudad de México, Mexico, 6Mental health outpatient clinic of the National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 7Rheumatology Departement at National Institute of Cardiology Ignacio Chavez - Universidad Autonoma del Estado de Hidalgo, Tula de Allende, Hidalgo, Mexico

    Background/Purpose: The clinical association of fibromyalgia with symptoms of anxiety and depression is well recognized [Uçar M, et al. J Int Med Res 2015;43(5):679-85]. Emotional…
  • Abstract Number: 0124 • ACR Convergence 2024

    Sexual Health Challenges in Primary Antiphospholipid Syndrome: Exploring Prevalence and Clinical Correlates

    Jonathan Campos-Guzmán1, María Espinosa-León2, Iris Paola García Herrera1, Iris Jazmín Colunga Pedraza3, Mariel Martínez-Ruiz1, Ana Barrera-Vargas4, Guillermo Guaracha Basañez5 and javier Merayo Chalico6, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico City, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Federal District, Mexico, 5Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirón", Mexico City, Mexico, 6Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, CDMX, Mexico

    Background/Purpose: Antiphospholipid syndrome (APS) is a systemic thromboinflammatory disease with various forms of presentation. There is limited information on sexual function in patients with APS,…
  • Abstract Number: 1676 • ACR Convergence 2024

    Changing Patients’ Mindsets About Non-Severe Side Effects of Methotrexate: A Randomized Controlled Trial

    Rachael Yielder1, Kari Leibowitz2, Alia Crum2, Paul Manley3, Nicola Dalbeth1 and Keith Petrie4, 1University of Auckland, Auckland, New Zealand, 2Stanford University, Palo Alto, CA, 3Te Whatu Ora Health New Zealand, Auckland, New Zealand, 4The University of Auckland, Auckland, New Zealand

    Background/Purpose: Although methotrexate (MTX) is a first-line treatment for inflammatory rheumatic diseases, side effects can lead to poor adherence and persistence. A novel intervention involves…
  • Abstract Number: 0165 • ACR Convergence 2024

    Exploring Changes in Daily Behaviors with Changes in Physical Function over 24 Weeks in Adults with Knee OA

    Thomas Videtich Bye1, Isabella Granetzke1, Sydney Liles2, Jennifer Copson3, Laura Schmitt1, Jason Jakiela4 and Daniel White1, 1University of Delaware, Newark, DE, 2University of Delaware, Elkton, MD, 3University of Delaware, Wilmington, DE, 4Winston-Salem State University, Winston-Salem, NC

    Background/Purpose: Knee osteoarthritis (OA) is a common cause of pain that often leads to limitations in physical function, e.g., difficulty walking or climbing stairs, in…
  • Abstract Number: 1723 • ACR Convergence 2024

    Clustering Analysis with Unsupervised Machine Learning Process to Phenotype the Cardiovascular Risk of Patients with Rheumatoid Arthritis Beyond the 10-year Prediction Algorithm

    Fabio Cacciapaglia1, Vincenzo Venerito2, Gian Luca Erre3, Matteo Piga4, Andreina Manfredi5, Garifallia Sakellariou6, Ombretta Viapiana7, Elisa Gremese8, Elena Bartoloni Bocci9, Francesca Romana Spinelli10 and Fabiola Atzeni11, and "Cardiovascular Obesity and Rheumatic DISeases" Study Group of the Italian Society of Rheumatology, 1Rheumatology Unit DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 2Rheumatology Unit, DiMePRe-J University of Bari, Bari, Italy, 3Rheumatology Unit - University of Sassari, Sassari, Italy, 4Rheumatology Unit - University of Cagliari, Cagliari, Italy, 5University of Modena and Reggio Emilia, Modena, 6Department of Internal Medicine and Medical Therapy, University of Pavia, and Istituti Clinici Scientifici Maugeri IRCCS Pavia,, Pavia, Italy, 7Rheumatology Unit, University of Verona, Verona, Italy, 8Catholic University of the Sacred Heart, Rome, Rome, Italy, 9Rheumatology Unit. Department of Medicine, Perugia, Perugia, Italy, 10Sapienza University of Rome, Rome - Italy, Roma, Rome, Italy, 11University of Messina, Italy, Messina, Italy

    Background/Purpose: Rheumatoid arthritis (RA) patients are at increased cardiovascular (CV) risk, but traditional CV risk factors and available 10-year CV risk estimation models may not…
  • Abstract Number: 0273 • ACR Convergence 2024

    Barriers and Facilitators for Outpatient Follow-Up After an Acute Gout Flare: A Qualitative Research Study

    Elizabeth Lopez1, Lesley Jackson2, Kenneth Saag3 and Maria I. ("Maio") Danila4, 1University of Alabama at Birmingham, Montgomery, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3The University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose: Many people with gout utilize the emergency department (ED) for acute gout care, but many do not receive subsequent adequate outpatient care for long-term…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology